Latest Partnerships News

Virgin Australia Holdings Limited is set to list on the ASX, raising $685 million through a mix of new and existing shares, showcasing its transformation journey and strategic partnership with Qatar Airways.

Mount Burgess Mining has raised $221,806 through a share placement aimed at advancing its Kihabe-Nxuu Project and supporting ongoing operations.

Excite Technology Services has landed a $676,000 contract with the Department of Home Affairs to enhance national digital forensics capabilities, marking a significant step in its government IT services growth.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Microba Life Sciences has raised $14.5 million to accelerate clinical adoption of its microbiome testing products, while narrowing its FY25 revenue guidance and signing a strategic UK laboratory agreement.

Diatreme Resources has announced a substantial upgrade to its Northern Silica Project’s Si2 Deposit, increasing the Measured Mineral Resource by 278% to 187.5 million tonnes. This milestone sets the stage for an upcoming Pre-Feasibility Study targeting a long-life silica sand operation.

Finder Energy has fast-tracked the development of its Kuda Tasi and Jahal oil fields in Timor-Leste through a strategic alliance with SLB, targeting initial production of up to 40,000 barrels per day. The company’s diversified portfolio and tight capital structure position it for multiple catalysts in the second half of 2025.

Jayride Group launches a new B2B SaaS platform aimed at transforming ground transportation with integrated payments, fleet management, and AI tools, promising higher margins and scalable growth.

Vection Technologies has secured a $2.6 million contract to co-develop SAFE-XR, an AI-powered safety compliance platform using augmented reality and wearable tech for industrial inspections in Italy.

Orion Minerals has obtained a $0.5 million unsecured loan facility from a company linked to its chairman, aimed at bolstering working capital ahead of potential funding events.

Optiscan Imaging Ltd has entered a five-year exclusive collaboration with Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein drug AK-FLOUR®, supporting US clinical trials and FDA regulatory submissions for Optiscan’s InVue® surgical device.

Metcash Limited reported solid FY25 financial results with revenue growth and market share gains across key pillars, underpinned by strategic acquisitions and operational improvements. The company enters FY26 with positive momentum and ongoing transformation initiatives.